Skip to main content

Tagged With "treatment"

Blog Post

AAFA Elevates Patient Voice in ICER Review of New Peanut Allergy Treatments

AAFA Community Services ·
On June 11, 2019, in Oakland, California, the Institute for Clinical and Economic Review (ICER) and its California Technology Assessment Forum (CTAF) met to assess the clinical effectiveness and value of treatments for peanut allergy. The review examined two new technologies to induce immune tolerance — Viaskin® Peanut (DBV Technologies) and AR101 (Aimmune Therapeutics) — as well as non-commercialized oral immunotherapy (OIT).
Blog Post Featured

Asthma and Allergy Foundation of America Responds to Premature ICER Review of New Peanut Allergy Treatments

AAFA Community Services ·
The Asthma and Allergy Foundation of America (AAFA) addresses concerns regarding the Final Evidence Report assessing the clinical effectiveness and value of treatments for peanut allergy released by the Institute for Clinical and Economic Review (ICER) on July 10, 2019. ICER’s report may cause concern for the allergy community that the findings will restrict access to new treatments for peanut allergy.
Blog Post

FDA Approves Cinqair to Treat Severe Asthma

AAFA Community Services ·
FDA News Release FDA approves Cinqair to treat severe asthma For Immediate Release March 23, 2016 Inquiries Media Andrea Fischer 301-796-0393 Consumers 888-INFO-FDA Release The U.S. Food and Drug Administration today approved Cinqair (reslizumab) for use with other asthma medicines for the maintenance treatment of severe asthma in patients aged 18 years and older. Cinqair is approved for patients who have a history of severe asthma attacks (exacerbations) despite receiving their current...
Blog Post

FDA Approves New Flu Treatment

AAFA Community Services ·
Today, the U.S. Food and Drug Administration approved Xofluza (baloxavir marboxil) for the treatment of acute uncomplicated influenza (flu) in patients 12 years of age and older who have been symptomatic for no more than 48 hours.
Blog Post

FDA Approves Symbicort to Treat Asthma In Children Ages 6-12

AAFA Community Services ·
AstraZeneca announced that the US Food and Drug Administration (FDA) approved SYMBICORT® (budesonide/formoterol fumarate dihydrate) Inhalation Aerosol 80/4.5 micrograms for the treatment of asthma in pediatric patients aged six up to 12 years.
Blog Post

FDA Approves Two New Asthma Inhalers

AAFA Community Services ·
[Press Release] Teva Announces FDA Approval of Two New RespiClick® Maintenance Inhalers for the Treatment of Asthma Approvals Expand Portfolio of Respiratory Medicines Delivered in RespiClick® Inhaler Designed to Eliminate the Need for Hand-Breath Coordination During Inhalation JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) announced that the U.S. Food and Drug Administration (FDA) approved two products for adolescent and adult patients with asthma.
Blog Post Featured

Help Shape the Future of Asthma Treatment

AAFA Community Services ·
Share your thoughts on the future of asthma treatment. Take two short surveys by Jan. 12, 2020, 11:59 p.m. ET, and we'll submit your responses to be considered for updates to the Guidelines for the Diagnosis and Management of Asthma.
Blog Post

How Do You Treat Your Eczema?

AAFA Community Services ·
There are a variety of treatments for eczema, including creams and ointments. But your doctor may also recommend moisturizing methods, like "soak and seal" and "wet wrapping." These therapies can help your topical medicines be more effective. Everyone's eczema is different, and there are many ways you can manage flare-ups. Talk to your doctor about therapies that may work best for you.
Blog Post

Teva Announces FDA Approval of QVAR® RediHaler™ Inhaler

AAFA Community Services ·
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that the U.S. Food and Drug Administration (FDA) has approved QVAR® RediHaler™ (beclomethasone dipropionate HFA) inhalation aerosol, a breath-actuated inhaler for the maintenance treatment of asthma as a prophylactic therapy in patients 4 years of age and older.
Blog Post

What Is a Biologic?

AAFA Community Services ·
Biologics are targeted therapies made from living organisms or natural sources. Biologic therapy involves injections every few weeks or so that are tailored to the individual. Biologics help normalize your immune system by controlling immune responses that lead to inflammation. There are biologic treatments available for people with moderate-to-severe asthma or atopic dermatitis (eczema).
Blog Post

Xolair Approved for Children with Asthma Triggered by Allergens

AAFA Community Services ·
There is a new drug available for children with uncontrolled asthma caused by airborne allergens. Xolair is already approved for people, ages 12 and older, with moderate to severe asthma. It belongs to a class of drugs called biologics. It is given in a doctor’s office by injection. The FDA recently approved it for children between ages 6 and 11 whose asthma is not controlled with other long-term medications . Approval makes Xolair the only biologic for children with uncontrolled allergic...
Blog Post

Living Life to Its Fullest One Year After Bronchial Thermoplasty

AAFA Community Services ·
Lexi Larabee, who has severe asthma, had bronchial thermoplasty one year ago and shared her experience with the Asthma and Allergy Foundation of America (AAFA). Below, Lexi tells us what her life has been like after the procedure.
Comment

Re: Living Life to Its Fullest One Year After Bronchial Thermoplasty

Melissa G ·
I absolutely love this!! So happy for you Lexi! What an inspiration you are to so many.
Comment

Re: Xolair Approved for Children with Asthma Triggered by Allergens

Sgp8136 ·
Thank you for sharing your experience. My 10 year old is going to be starting Xolair very soon, we finally got the approval from our insurance. I’m hoping this is just what she needs. She has been hospitalized so many times and is constantly absent from school because of her asthma not to mention all the steroids she’s taken. We’ve tried so many different preventative medications and it just isn’t enough. I hope all goes well and there aren’t any side effects the possibility of that is...
Comment

Re: Xolair Approved for Children with Asthma Triggered by Allergens

K8sMom2002 ·
Welcome, SGP8136! I am hoping that your daughter will do well on the Xolair and will see improvements! Please know that you guys aren't alone as you go along ... you'll find plenty of support on AAFA's Asthma Support Community .
Comment

Re: Xolair Approved for Children with Asthma Triggered by Allergens

JadesJourney ·
Jade just started her first round of Xolair Injections this past week. She's SO brave! But...I have to admit...It was a bittersweet moment; watching her sit there, calm, asking the nurse to count slowly for her, watching the needle, as she was given both injections. Outside of respectfully saying that it "kind of hurt, a lot", she didn't complain, or cry, or move, or refuse, or scream...she just sat still and watched! As a mom, this was a like a dream come true...at first. [{Sidebar} At this...
Comment

Re: Xolair Approved for Children with Asthma Triggered by Allergens

Jen ·
@JadesJourney That is great that Jade is so brave during those shots. We have other members who have been on xolair as well and have discussed their experiences on our support forums.
Comment

Re: Xolair Approved for Children with Asthma Triggered by Allergens

K8sMom2002 ·
I totally get what you're saying here, @JadesJourney ... fingers crossed that these shots will give her some control over her asthma that has been lacking! WTG on you helping guide her so that she CAN ask those "big girl" questions about the medications she's on. Hang tight, Mama!
Comment

Re: Xolair Approved for Children with Asthma Triggered by Allergens

Jen ·
@JadesJourney How are things going with the Xolair?
Comment

Re: Teva Announces Two More Digital Inhalers for Asthma - AirDuo® Digihaler® and ArmonAir® Digihaler®

Compton ·
Welcome @JHill . Thank you for joining. The other members here know what it's like to come away from a diagnosis and wonder 'what's next?' May I recommend a very active forum called Asthma Support. Feel free to start your topic and ask any questions you have, Another good place to start is the Asthma Symptoms page. There is a guide at the bottom for the newly diagnosed - Your Guide to Managing Asthma . We're all cheering for you!
Blog Post

Teva Announces Two More Digital Inhalers for Asthma - AirDuo® Digihaler® and ArmonAir® Digihaler®

AAFA Community Services ·
Teva Respiratory, LLC., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. announced the launch of AirDuo® Digihaler® (fluticasone propionate and salmeterol) inhalation powder and ArmonAir® Digihaler® (fluticasone propionate) inhalation powder, two digital maintenance inhalers for patients with asthma. AirDuo® Digihaler® is a prescription medicine used to control symptoms of asthma and to prevent symptoms such as wheezing in people 12 years of age and older.
Comment

Re: Asthma Diagnosis, Management, and Treatment in the U.S. Is Changing – What the New Guidelines Say

ThisBreath ·
This is huge news! I need to connect with my pulmonologist. Could you please make an Instagram post about these changes? Would like to spread the info . Thank you!
Comment

Re: Asthma Diagnosis, Management, and Treatment in the U.S. Is Changing – What the New Guidelines Say

Kathy P ·
Hi This breath - we are posting this information in our different social channels. And we have more information coming.
Blog Post Featured

Asthma Diagnosis, Management, and Treatment in the U.S. Is Changing – What the New Guidelines Say

AAFA Community Services ·
On Dec. 3, 2020, the National Institutes of Health (NIH) announced updates to the clinical guidelines used to diagnose and manage asthma. The new guidelines are titled "The 2020 Focused Updates to the Asthma Management Guidelines: A Report from The National Asthma Education and Prevention Program Expert Panel Working Group." The National Heart, Lung, and Blood Institute (NHLBI), part of the NIH, oversaw the National Asthma Education and Prevention Program Coordinating Committee (NAEPPCC) and...
Comment

Re: Asthma Diagnosis, Management, and Treatment in the U.S. Is Changing – What the New Guidelines Say

mdashiquennobi ·
This is a great news indeed. For all of us.
Blog Post

Ultraviolet Environmental Treatment Could Help Children With Mild-Moderate Asthma

AAFA Community Services ·
Research to be presented at the 2021 American Academy of Allergy, Asthma & Immunology (AAAAI) Virtual Annual Meeting suggests that installing ultraviolet irradiation units into the homes of children with asthma may reduce asthma severity and improve asthma control.
Blog Post Featured

Know How to Use Your Emergency Medicines to Treat Asthma and Allergy Symptoms

AAFA Community Services ·
When you have asthma or allergies, it is important that you know both how and when to use your medicines before you have a medical emergency. When you have asthma, you may have more than one medicine to both prevent and treat asthma emergencies.
Blog Post

FDA Approves Xolair® (Omalizumab) Prefilled Syringe for Self-Injection

AAFA Community Services ·
Novartis today announced that the US Food and Drug Administration (FDA) approved the supplemental Biologics License Application for Xolair® (omalizumab) prefilled syringe for self-injection in appropriate patients across all approved US indications.1 Xolair is the only FDA-approved biologic designed to target and block immunoglobulin E (IgE) for the treatment of moderate to severe persistent allergic asthma, chronic idiopathic urticaria (CIU) and nasal polyps.
Comment

Re: FDA Approves Xolair® (Omalizumab) Prefilled Syringe for Self-Injection

Kathy P ·
If you are currently on Xolair or considering it, what are your thoughts about self injections? Excited that this will make things more convenient? Apprehensive about doing the shots at home instead of a clinic? Join the discussion !
Comment

Re: FDA Approves Xolair® (Omalizumab) Prefilled Syringe for Self-Injection

katalinfrog ·
I've been on Xolair injections for 8 months now, and we're doubling my dose since my IgE levels are still very high. Even though the FDA has approved injecting at home, my physician's office is still apprehensive about allowing me to inject at home. I have Epi pens and I'm ready to make the switch. It will save me an hour round trip, and $65 per injection. Is it typical for doctor's offices to be nervous about switching?
Blog Post

Asthma Health Q&A: Management, New Guidelines, and COVID-19 Vaccines (Twitter Chat)

AAFA Community Services ·
The Asthma and Allergy Foundation of America (AAFA) hosted a Twitter chat on asthma health on May 3, 2021. The American Academy of Allergy, Asthma & Immunology (AAAAI) and David Stukus, MD , associate professor and Director of the Food Allergy Treatment Center at Nationwide Children’s Hospital, joined us to answer common questions about managing asthma, asthma treatment guidelines, and COVID-19 vaccines. Below are some highlights from the chat. To see more, search for the hashtag...
Blog Post

Astepro Nasal Antihistamine Spray Is Approved to Be Sold Without a Prescription

AAFA Community Services ·
The U.S. Food and Drug Administration today approved a nasal antihistamine for nonprescription use through a process called a partial prescription to nonprescription switch. The FDA approved Astepro (azelastine hydrochloride nasal spray, 0.15%) for seasonal and perennial allergic rhinitis—commonly known as allergies—for adults and children six years of age and older.
Blog Post

[Sponsored] Understanding Asthma in Children

AAFA Community Services ·
We thank Omron Healthcare, Inc. for their sponsorship of this blog post to help us share information about asthma in children. This is a sponsored post and is not an endorsement of any company or its products, nor is it a guarantee of the products’ safety. The funding we received for this advertisement helps support our free asthma and allergy programs. Asthma affects 5.1 million American children. 1 It is one of the most common serious chronic disease in kids. The burden of asthma is even...
Blog Post

Sarah Michelle Gellar and Teva Team Up to Help People With Asthma and COPD Improve Inhaler Use

AAFA Community Services ·
Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd., today announced the launch of Inhaler Tales – a national campaign aimed at raising awareness about the role inhaler misuse may play in inadequate disease control. Central to the campaign is an animated inhaler voiced by actress, producer, and entrepreneur Sarah Michelle Gellar, who will share her own experience living with asthma and encourage others to take control of their disease.
×
×
×
×